Expression of a single inhibitory member of the Ly49 receptor family is sufficient to license NK cells for effector functions
eLife · 2025
DOI: 10.7554/elife.100218 ↗Kurz gefasst
Fachartikel in der Zeitschrift eLife, 2025. Verfasst von Sytse J Piersma und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Rheumatology, Department of Medicine, Washington University School of Medicine, St Louis, United States. Hauptthemen laut MEDLINE: Killer Cells, Natural, NK Cell Lectin-Like Receptor Subfamily A. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Natural killer (NK) cells recognize target cells through germline-encoded activation and inhibitory receptors enabling effective immunity against viruses and cancer. The Ly49 receptor family in the mouse and killer immunoglobin-like receptor family in humans play a central role in NK cell immunity through recognition of major histocompatibility complex class I (MHC-I) and related molecules. Functionally, these receptor families are involved in the licensing and rejection of MHC-I-deficient cells through missing-self. The Ly49 family is highly polymorphic, making it challenging to detail the contributions of individual Ly49 receptors to NK cell function. Herein, we showed mice lacking expression of all Ly49s were unable to reject missing-self target cells in vivo, were defective in NK cell licensing, and displayed lower KLRG1 on the surface of NK cells. Expression of Ly49A alone on an H-2D d background restored missing-self target cell rejection, NK cell licensing, and NK cell KLRG1 expression. Thus, a single inhibitory Ly49 receptor is sufficient to license NK cells and mediate missing-self in vivo.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Rheumatology, Department of Medicine, Washington University School of Medicine, St Louis, United States.
- Siteman Cancer Center, Washington University School of Medicine, St Louis, United States.
- Division of Oncology, Department of Medicine, Washington University School of Medicine, St Louis, United States.
- Department of Pathology and Immunology, Washington University School of Medicine, St Louis, United States.
- Bursky Center for Human Immunology and Immunotherapy Programs, Washington University School of Medicine, St. Louis, United States.
ORCID-Profile: Sytse J Piersma, Shasha Li, Wayne M Yokoyama
Förderung
- NIH HHS
- National Institutes of Health
Zitieren
APA
Piersma, S. J., Li, S., Wong, P., Bern, M. D., Poursine-Laurent, J., Yang, L., Beckman, D. L., Parikh, B. A., & Yokoyama, W. M. (2025). Expression of a single inhibitory member of the Ly49 receptor family is sufficient to license NK cells for effector functions. eLife. https://doi.org/10.7554/elife.100218
Vancouver
Piersma SJ, Li S, Wong P, Bern MD, Poursine-Laurent J, Yang L, et al. Expression of a single inhibitory member of the Ly49 receptor family is sufficient to license NK cells for effector functions. eLife. 2025. doi:10.7554/elife.100218
BibTeX
@article{Piersma2025,
author = {Piersma, Sytse J and Li, Shasha and Wong, Pamela and Bern, Michael D and Poursine-Laurent, Jennifer and Yang, Liping and Beckman, Diana L and Parikh, Bijal A and Yokoyama, Wayne M},
title = {Expression of a single inhibitory member of the Ly49 receptor family is sufficient to license NK cells for effector functions},
journal = {eLife},
year = {2025},
doi = {10.7554/elife.100218}
}
EUVIMED